Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier

被引:142
作者
Jensen, JM
Schütze, S
Förl, M
Krönke, M
Proksch, E
机构
[1] Univ Kiel, Dept Dermatol, D-24105 Kiel, Germany
[2] Univ Kiel, Inst Immunol, D-24105 Kiel, Germany
关键词
D O I
10.1172/JCI5307
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Epidermal TNF expression increases in response to cutaneous permeability barrier disruption and wound healing. TNF signaling is mediated by acid and neutral sphingomyelinases (A- and N-SMase), which generate ceramide, an important regulator of proliferation, differentiation, and apoptosis. In the epidermis, ceramide is known to be an integral part of the extracellular stratum corneum (SC) lipid bilayers that constitute the permeability barrier of the skin. We show here that topical application of TNF after experimental injury to the SC of hairless mice (hr(-/-)) enhances barrier repair. In TNF receptor p55-deficient (TNF-R55-deficient) mice (hr(+/+)), cutaneous barrier repair was delayed compared with wild-type (hr(+/+)) or TNF-R75-deficient (hr(+/+)) animals. After barrier disruption in hairless (hr(-/-)) and wild-type (hr(+/+)), but not in TNF-R55-deficient (hr(+/+)) mice, the enzymatic activities of both A-SMase and N-SMase were significantly enhanced. Stimulation of SMase activities was accompanied by an increase in C-24-ceramide levels. Most A-SMase activity in hairless mice (hr(-/-)) was found in the outer epidermal cell layers and colocalized in the lamellar bodies with A-SMase and sphingomyelin. Reduction of epidermal A-SMase activity by the inhibitor imipramine resulted in delayed permeability barrier repair after SC injury. Together, these results suggest that TNF-R55 signaling pathways contribute to cutaneous permeability barrier repair through SMase-mediated generation of ceramide.
引用
收藏
页码:1761 / 1770
页数:10
相关论文
共 60 条
[1]   FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase [J].
AdamKlages, S ;
Adam, D ;
Wiegmann, K ;
Struve, S ;
Kolanus, W ;
SchneiderMergener, J ;
Kronke, M .
CELL, 1996, 86 (06) :937-947
[2]  
ALBOUZ S, 1981, BIOMED EXPRESS, V35, P218
[3]   SPHINGOLIPIDS AND CELL-FUNCTION [J].
BALLOU, LR .
IMMUNOLOGY TODAY, 1992, 13 (09) :339-341
[4]   Ceramide signalling and the immune response [J].
Ballou, LR ;
Laulederkind, SJF ;
Rosloniec, EF ;
Raghow, R .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1301 (03) :273-287
[5]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[6]   SPHINGOMYELINASE IN PIG AND HUMAN EPIDERMIS [J].
BOWSER, PA ;
GRAY, GM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1978, 70 (06) :331-335
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   MULTIPLE PATHWAYS ORIGINATE AT THE FAS/APO-1 (CD95) RECEPTOR - SEQUENTIAL INVOLVEMENT OF PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE-C AND ACIDIC SPHINGOMYELINASE IN THE PROPAGATION OF THE APOPTOTIC SIGNAL [J].
CIFONE, MG ;
RONCAIOLI, P ;
DEMARIA, R ;
CAMARDA, G ;
SANTONI, A ;
RUBERTI, G ;
TESTI, R .
EMBO JOURNAL, 1995, 14 (23) :5859-5868
[9]   Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity [J].
De Maria, R ;
Testi, R .
IMMUNOLOGY TODAY, 1998, 19 (03) :121-125
[10]  
Di Nardo A, 1998, ACTA DERM-VENEREOL, V78, P27